I N recent months makers of weight-loss drugs have gone on a crash diet. In late July Novo Nordisk, the Danish firm that gave ...

Because of its size, the drugmaker has an outsize effect on the country. Now, as it sheds jobs, forecasts for Denmark’s ...

Danish pharmaceutical company Novo Nordisk is preparing to introduce its innovative weight management drug, Ozempic ...

Novo Nordisk's Q2 2025 sales surge as Wegovy demand grows, driven by new obesity drug data. Click here to read an analysis of ...

Ozempic, marketed by Novo Nordisk in India, is primarily indicated for the treatment of type 2 diabetes. While it can lead to ...

Firm Novo Nordisk’s global patent is set to expire in parts of the world from early 2026, allowing cut-price ‘own-label’ versions of Wegovy and Ozempic to be sold, according to reports ...

Online pharmacies are using a loophole to continue selling cheap weight loss drugs that are modeled on Ozempic and Mounjaro, ...

Gates Foundation and Novo Nordisk Novo Nordisk Foundation have extended the Acetate Consortium initiative with a $25.6M ...

The pharmaceutical company that has become central to the Danish economy is readying to cut some 5,000 jobs in its home ...

Novo Nordisk issued sales and profit warnings in July, and its share price was hammered, losing 20% or more in a single day.

U.S. President Donald Trump on Thursday unveiled a 100% tariff on imports of branded drugs from October 1, unless their ...

Discover how Trump’s 100% drug tariff impacts NVO, SNY, and AZN stocks. Click for which pharma giants face the most risk—and ...